Study on the Canine Adenovirus Type 1 (CAdV-1) Infection in Domestic Dogs in Southern Italy [PDF]
Pathogens, 2022 Canine adenovirus type 1 (CAdV-1) is the causative agent of a systemic and potentially fatal viral disease of domestic and wild canids. In Italy, CAdV-1 infection has also been occasionally described in dogs, but information on the epidemiology and its ...
Vincenza Cannella +2 more
exaly +7 more sources
Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes [PDF]
Frontiers in Veterinary Science, 2022 Canine adenovirus type 1 (CAdV-1) is the etiologic agent of fox encephalitis. As with most viral agents, the best method of prevention is vaccination.
Xiaoyu Deng, Yanzhu Zhu
exaly +4 more sources
Canine Adenoviruses in Wildlife: Role in At-Risk Species Conservation and Interface with Domestic Animals [PDF]
PathogensCanine adenovirus type 1 (CAdV-1) and type 2 (CAdV-2) are well known pathogens of domestic dogs but are little investigated in wild animals. The few available studies about CAdV-1 in wild animals show that it circulates in various species and that ...
Andrea Balboni +2 more
exaly +4 more sources
Genetic Characteristics of Canine Adenovirus Type 2 Detected in Wild Raccoon Dogs (Nyctereutes procyonoides) in Korea (2017–2020) [PDF]
Veterinary Sciences, 2022 Adenovirus has been detected in a wide range of hosts like dogs, foxes, horses, bats, avian animals, and raccoon dogs. Canine adenoviruses with two serotypes host mammals and are members of the mastadenovirus family. Canine adenovirus type 1 (CAdV-1) and
Yoon-Ji Kim +5 more
doaj +2 more sources
Unique genetic features of canine adenovirus type 1 (CAdV-1) infecting red foxes (Vulpes vulpes) in northern Norway and arctic foxes (Vulpes lagopus) in Svalbard [PDF]
Veterinary Research Communications, 2019 Canine adenovirus type 1 (CAdV-1) is the aetiological agent of infectious canine hepatitis (ICH) in domestic dogs (Canis familiaris). In spite of the widespread use of vaccination, CAdV-1 continues to circulate in the dog population. Although a high number of serological screenings have indicated that CAdV-1 is widespread in fox species, little is ...
Morten Tryland +2 more
exaly +5 more sources
Prevalence of Serum Antibody Titers against Core Vaccine Antigens in Italian Dogs [PDF]
Life, 2023 Canine vaccination is the main tool for preventing dangerous and widespread diseases. The strongly recommended (core) dog vaccines are against Canine Parvovirus type 2 (CPV-2), Canine Distemper Virus (CDV), and Canine Adenovirus (CAdV-1), but vaccination
Paola Dall’Ara +8 more
doaj +2 more sources
Semina: Ciências Agrárias, 2014 Bovine babesiosis is an important disease of cattle where Rhipicephalus microplus acts as a vector for the two causal organisms Babesia bovis and Babesia bigemina.
Ana Paula Silva +4 more
doaj +3 more sources
Canine Adenovirus 1 Isolation Bioinformatics Analysis of the Fiber [PDF]
Frontiers in Cellular and Infection Microbiology, 2022 Canine adenovirus type 1 (CAdV-1) is a double-stranded DNA virus, which is the causative agent of fox encephalitis. The Fiber protein is one of the structural proteins in CAdV-1, which mediates virion binding to the coxsackievirus and adenovirus receptor
Ben Wang +7 more
doaj +2 more sources
Difference Analysis Between Canine Adenovirus Types 1 And 2 [PDF]
Frontiers in Cellular and Infection Microbiology, 2022 Canine adenoviruses (CAdVs) include type 1 (CAdV-1, virulent strain) and type 2 (CAdV-2, attenuated strain). In recent years, the incidences of CAdV infections are increasing. However, they are difficult to distinguish when the symptoms are untypical. It
Yanzhu Zhu +8 more
doaj +2 more sources
Adenovirus entry: Stability, uncoating, and nuclear import
Molecular Microbiology, Volume 118, Issue 4, Page 309-320, October 2022., 2022 Viruses invade organisms and cells, cause disease, persist for a lifetime, or are eliminated by host defense. Viral vectors are beneficial to clinical therapy or preventive vaccination. Adenoviruses are widespread human pathogens and the most widely used vectors in gene therapy.
Urs F. Greber, Maarit Suomalainen
wiley +1 more source